Active neurons increase their energy supply by dilating nearby arterioles and capillaries. This neurovascular coupling underlies blood oxygen level-dependent functional imaging signals, but its mechanism is controversial. Canonically, neurons release glutamate to activate metabotropic glutamate receptor 5 (mGluR5) on astrocytes, evoking Ca 2+ release from internal stores, activating phospholipase A2 and generating vasodilatory arachidonic acid derivatives. However, adult astrocytes lack mGluR5, and knockout of the inositol 1,4,5-trisphosphate receptors that release Ca 2+ from stores does not affect neurovascular coupling. We now show that buffering astrocyte Ca 2+ inhibits neuronally evoked capillary dilation, that astrocyte [Ca 2+ ] i is raised not by release from stores but by entry through ATP-gated channels, and that Ca 2+ generates arachidonic acid via phospholipase D2 and diacylglycerol kinase rather than phospholipase A2. In contrast, dilation of arterioles depends on NMDA receptor activation and Ca 2+ -dependent NO generation by interneurons. These results reveal that different signaling cascades regulate cerebral blood flow at the capillary and arteriole levels.
a r t I C l e S Functional hyperemia is the phenomenon by which active brain regions induce a local increase in blood flow to match their energy demands, via a process termed neurovascular coupling. Traditionally, regulation of cerebral blood flow was thought to occur at the level of arterioles [1] [2] [3] . However, capillaries in the brain are also wrapped by contractile cells called pericytes 4 , which can respond to neuronal activity and control blood flow at a more local level than arterioles 5, 6 . Although neurovascular coupling is the basis of blood oxygen leveldependent (BOLD) functional magnetic resonance imaging (fMRI), an increasingly routine method used to measure brain activity in the clinic and in cognitive studies, our understanding of the underlying signaling mechanisms is still incomplete.
Neurovascular coupling can partly occur as a result of direct signaling from neurons to the vasculature 7 . However, over the last decade, a role for astrocytes, which have endfoot processes near blood vessels, has also been demonstrated: neurons signal to astrocytes, which in turn release vasoactive substances onto vessels 8 . Initial data suggesting astrocyte-mediated neurovascular signaling came from experiments in which stimulating neurons led to a rise in astrocyte [Ca 2+ ] i , as well as arteriole dilation 1 . It was further shown that raising astrocyte [Ca 2+ ] i evokes vascular dilations and constrictions 2, 3, 9 , which were produced by metabolites of arachidonic acid (AA) generated by phospholipase A2 (PLA2). Dilation occurs via the formation of prostaglandin E 2 (PGE 2 ) and epoxyeicosatrienoic acids (EETs), while production of 20-hydroxyeicosatetraenoic acid (20-HETE) results in constriction (see ref. 8 for review).
Although these findings were obtained in several laboratories, controversies still abound. Astrocyte Ca 2+ signals may be too small or slow 10 , or too infrequent 11 , to have a causative role in neurovascular coupling. However, these conclusions were based on measuring Ca 2+ signals within astrocyte cell bodies, rather than in the fine processes 12 of astrocytes near synapses that are presumably the first responders to neuronal activity. Indeed, recent in vivo studies have reported rapid, physiological stimulation-evoked [Ca 2+ ] i rises in astrocyte somata and endfeet in the somatosensory cortex 13 , and in the processes but not the somata of olfactory bulb astrocytes 14 .
A second controversy concerns how elevations of astrocyte Ca 2+ concentration are generated. While these were originally thought to reflect activation of mGluR5 and downstream inositol 1,4,5-trisphosphate (IP 3 )-dependent release of Ca 2+ from internal stores [1] [2] [3] , recent studies show that mGluR5 expression is downregulated in astrocytes from adult animals 15 . Furthermore, animals lacking IP 3 R2, the primary IP 3 receptor in astrocytes, display unaltered neurovascular coupling 16 . Nevertheless, there are other mechanisms that could raise astrocyte [Ca 2+ ] i , including Ca 2+ -permeable AMPA receptors 17 , NMDA receptors 18 , ATP receptors 19 and TRPA1 channels 20 , and thus mediate astrocyte-to-vessel signaling.
Finally, it is unclear whether neurovascular coupling at the capillary level is mediated by the same pathways as that at the arteriole level. Although dilation of capillaries and arterioles both rely on relaxation of actomyosin, in pericytes and in arteriolar smooth muscle respectively, it seems plausible that local (capillary) and spatially broader (arteriolar) control of blood flow might be driven by different signaling pathways.
Here we investigated the role of astrocytes in mediating neurovascular coupling in the cerebral cortex, in brain slices and in vivo. We provide, to our knowledge, the first direct demonstration that a rise in astrocyte [Ca 2+ ] i is necessary for neuronally evoked capillary dilation to occur. We show that the source of Ca 2+ involved in this process and its molecular effects are different from what was previously believed. a r t I C l e S We also show that arteriole dilation is not mediated by astrocyte Ca 2+ signaling, but instead depends on NMDA receptor-mediated nitric oxide release (Supplementary Fig. 1 ).
RESULTS

Neuronal activity evokes capillary dilation
We assessed whether cerebral cortical capillaries can respond to electrically stimulated synaptic activity in cortical slices from P21 (adolescent) rats. Stimulation-evoked fiber volley and field excitatory postsynaptic currents (fEPSCs) were recorded in all experiments to confirm activation of the neuropil near the capillary being studied (Supplementary Fig. 2 ). Vascular responses are known to be modulated by the oxygen concentration in the tissue: physiological [O 2 ] produced by bubbling the superfusate with 20% O 2 results in larger dilations 6, 9, 21 . Therefore, all experiments reported here were conducted using 20% O 2 . Furthermore, since vessels in brain slices do not have resting tone due to a lack of noradrenergic signaling from the locus coeruleus and a lack of perfusion pressure and blood flow, a vasoconstricting agent is required to provide the resting tone upon which neuronally evoked dilations normally occur 22 . We bath-applied the thromboxane A 2 analog U46619 (200 nM) for at least 5 min to preconstrict cortical vessels before neuronal stimulation. Capillaries were identified as vessels <10 µm wide that lacked a continuous layer of smooth muscle 22 (Supplementary Fig. 2 ). U46619 constricted capillaries by 18.7 ± 0.7% (all data are presented as mean ± s.e.m.) at n = 213 separate capillary regions (presumed locations of pericytes) in 112 vessels from 70 animals ( Fig. 1a,b and Supplementary Fig. 3 ) within minutes, without affecting electrically evoked synaptic activity ( Supplementary Fig. 2c,d) , and this constriction was maintained for at least 30 min ( Supplementary Fig. 3a) . Electrically stimulated neuronal activity then dilated the capillaries by 14.5 ± 0.5% ( Fig. 1a,b) .
We first confirmed that stimulation-evoked capillary dilation resulted from neuronal activity and not direct stimulation of the vasculature. In the presence of tetrodotoxin (TTX, 500 nM), stimulation-evoked neuronal activity (the fiber volley and fEPSCs) was completely abolished (Supplementary Fig. 2c ) and capillary responses were also absent (0.2 ± 1.6% dilation, n = 11; Fig. 1c ,f) unlike in interleaved controls (14.0 ± 1.6% dilation, n = 7, significantly different, P = 0.00008 ( Fig. 1f ; all statistical tests used are described in detail in the "Statistics" section of the Online Methods and in the Supplementary Methods Checklist). Blocking ionotropic glutamate receptors showed that postsynaptic activity was necessary for neurovascular signaling to capillaries. The AMPA and kainate receptor blocker NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide, 10 µM) inhibited stimulation-evoked fEPSCs ( Supplementary Fig. 2c,d ) and reduced capillary dilation by 82.2% (P = 0.002; Fig. 1d,g) . In contrast, the NMDA receptor blocker d-AP5 (d-(-)-2-amino-5-phosphonopentanoic acid; 25 µM) had no effect on stimulation-evoked capillary dilation (P = 0.6; Fig. 1e,h) . Thus, stimulation-evoked capillary dilation reflects action potential-driven glutamatergic synaptic activity but does not depend on Ca 2+ entry into neurons via NMDA receptors.
Capillary dilation is mediated by Ca 2+ -dependent astrocyte signaling
We next investigated whether astrocyte Ca 2+ signaling mediates neuron-to-capillary signaling. To address this, astrocytes near the vessel of interest were whole-cell patch-clamped and dialyzed with either a control internal solution containing 1 mM EGTA (ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid) or one containing 30 mM of the faster Ca 2+ chelator BAPTA (1,2-bis(2aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid). Spread of the pipette solution between astrocytes via gap junctions was visualized using the dye Alexa Fluor 488 (40 µM). After 10-15 min of dialysis, the astrocyte network, including endfeet along the vessel of interest, was filled with Alexa Fluor 488 ( Fig. 2a) . Stimulating neuronal activity when astrocytes were dialyzed with the control (EGTA) internal solution evoked robust capillary dilations (16.2 ± 1.7%, n = 12; Fig. 2b,c) . However, when astrocytes were dialyzed with BAPTA to buffer rises in [Ca 2+ ] i , stimulation-evoked dilation was reduced by 64% to 5.9 ± 2.0% (n = 17, P = 0.0007; Fig. 2b,c) . The free [Ca 2+ ] i in both the EGTA and BAPTA internal solutions was set to ~24 nM, so the effects observed are not attributable to differences in baseline free [Ca 2+ ] i , implying that a transient rise in astrocyte [Ca 2+ ] i in response to neuronal stimulation is, at least in part, necessary for neurovascular signaling to capillaries.
In some experiments, we imaged vessels as the internal solution spread from the patch-clamped astrocyte into the endfoot processes, to observe whether buffering astrocyte Ca 2+ rises had any effect on baseline capillary diameter. There was no significant change in the baseline diameter of the vessels when using either the control internal solution (2.0 ± 1.8% constriction in 4 capillaries, not significantly different from zero, P = 0.3) or the BAPTA internal (5.4 ± 3.2% dilation in 8 capillaries; not significantly different from zero, P = 0.1; diameter change in BAPTA was not significantly different from that in EGTA, P = 0.2).
P2X1 receptors raise astrocyte [Ca 2+ ] i
Many mechanisms leading to a [Ca 2+ ] i rise in astrocytes have been suggested. Group I metabotropic glutamate receptors (mGluR1 and a r t I C l e S mGluR5) 23 and the ATP receptor P2Y1 (ref. 24 ) are both G-proteincoupled receptors associated with Gα q signaling that induces Ca 2+ release from internal stores by generating IP 3 . In particular, mGluR5 has long been thought to be the primary cause of astrocyte [Ca 2+ ] i rises 23 . Recently, group II mGluRs were also shown to raise [Ca 2+ ] i in astrocytes via an as yet undefined mechanism 25 . Furthermore, the Ca 2+ -permeable heteromeric ATP receptor P2X1/5 (ref. 19 ) and transient receptor potential A1 (TRPA1) channels 20 are also possible routes for Ca 2+ influx into astrocytes. We tested the role of each of these receptors in mediating capillarylevel neurovascular coupling. Stimulation-evoked capillary dilation was not reduced after bath application of a nonspecific blocker of both group I and II mGluRs, (S)-MCPG ((S)-α-methyl-4-carboxyphenylglycine, 1 mM, P = 0.1; Fig. 2d,i) , the P2Y1 receptor blocker MRS2179 (25 µM, P = 0.8; Fig. 2e ,j) or the TRPA1 blocker A967079 (10 µM, P = 0.3; Fig. 2f,k) . However, the P2X1 blockers NF449 (100 nM; Supplementary Table 1 ) and NF023 (5 µM) reduced the stimulation-evoked capillary dilation by 58% (P = 0.0007; Fig. 2g ,l) and 94% (P = 0.001; Supplementary Fig. 4d ), respectively. Similar results were obtained using shorter stimulation durations than the 1 min used above (NF449 reduced dilation by 94% (P = 0.005) and 60% (P = 0.01) for 200 ms and 5 s stimulation, respectively; Supplementary Fig. 4a-c) , and in P45 mice (66% reduction with NF449, P = 0.00008 using 5 s stimulation; Supplementary Fig. 4e ).
If P2X1 receptors raise astrocyte [Ca 2+ ] i to evoke the dilation, then we should also be able to evoke dilation simply by activating this receptor. Indeed, a 5-s puff application of α,β-methylene-ATP (100 µM; Online Methods), an agonist for P2X1 (ref. 26) , onto the neuropil induced a 10.7 ± 2.3% dilation of cortical capillaries, whereas application of vehicle did not (0.4 ± 1.3% constriction, significantly different, P = 0.0007; Fig. 2h,m) . These data suggest that capillarylevel neurovascular coupling occurs largely through a P2X1 receptordependent pathway in astrocytes.
To study stimulation-evoked changes in [Ca 2+ ] i in astrocyte endfeet, we whole-cell clamped astrocytes to selectively fill them with the membrane-impermeant Ca 2+ indicator dye Fluo-4 (50 µM), along with a reference dye (Alexa Fluor 594, 40 µM) to allow ratiometric imaging, as ratio R = (Fluo-4 intensity)/(Alexa Fluor 594 intensity). We observed spontaneous local Ca 2+ transients in astrocyte cell bodies and processes, as previously reported [27] [28] [29] . Stimulating neuronal activity evoked an increase in [Ca 2+ ] i in astrocytes (∆R/R = 41.4 ± 11.7% in endfeet, n = 9, P = 0.003 compared to zero; ∆R/R = 58.4 ± 20.2% in processes, n = 23, P = 0.006; ∆R/R = 60.2 ± 24.3% in somata, n = 13, P = 0.02; Fig. 3a-c) . The amplitude of this signal was reduced by 81% and 85% in endfeet and processes, respectively, by the P2X1 receptor blocker NF449 (∆R/R = 7.9 ± 3.1% in endfeet, n = 6, P = 0.02 compared to control data; ∆R/R = 8.5 ± 3.4% in processes, n = 14, P = 0.02; Fig. 3b,c) . NF449 did not significantly block the calcium rise in somata ( Fig. 3c) . These data are consistent with P2X1 receptor-mediated signaling in astrocytes mediating the In contrast, the mGluR blocker (S)-MCPG (1 mM) did not alter the [Ca 2+ ] i changes in the endfoot, process or soma ( Fig. 3c) .
Arachidonic acid metabolites mediating capillary dilation
Astrocyte-mediated neurovascular coupling is thought to occur via the synthesis of AA by Ca 2+ -activated phospholipase A2 followed by metabolism into vasoactive substances 8 such as prostaglandins (by the activity of cyclooxygenase (COX)) or EETs (by the activity of epoxygenases). We tested the contribution of these enzymes using specific inhibitors. The COX1 inhibitor SC-560 (1 µM) reduced the stimulation-evoked capillary dilation by 64% (P = 0.0002; Fig. 4a,d) , but the COX2 inhibitor NS-398 (10 µM; Fig. 4b,e ) and the epoxygenase inhibitor PPOH (2-(2-propynyloxy)-benzenehexanoic acid, 25 µM; Fig. 4c,f ) had no effect on the dilation. COX1 generates several prostaglandin derivatives, including the vasodilators PGE 2 and PGI 2 . Blocking the EP4 receptor for PGE 2 with L-161,982 (1 µM) reduced the stimulationevoked dilation by 72% (P = 0.004; Fig. 4g,j) . In contrast, blocking the prostaglandin I 2 (IP) receptor for PGI 2 with CAY10441 (1 µM) did not affect the dilation (Fig. 4h,k) . Nitric oxide has also been shown to contribute to arteriolar vasodilation in the cortex 30, 31 ; however, when the NO synthase (NOS) inhibitor N G -nitro-l-arginine (l-NNA; 100 µM) was applied, stimulation-evoked capillary dilation was not reduced (Fig. 4i,l) , implying that NO does not contribute to capillary dilation in the cortex. Thus, PGE 2 generated by COX1 and acting on EP4 receptors is the primary vasoactive signal mediating capillary dilation. We used immunohistochemistry to investigate the cellular location of the enzymes metabolizing AA. We found COX1 labeling in processes along arterioles and capillaries that colabeled for aquaporin 4 (AQP4), a protein highly expressed in astrocyte endfeet (Supplementary Fig. 5a ). In contrast, COX2 did not colocalize with the astrocyte structural protein glial fibrillary acidic protein (GFAP), but was expressed diffusely in the neuropil with higher expression in neuronal somata (Supplementary Fig. 5b) . Antibodies against the CYP2C11 isoform of epoxygenase, reported to be the predominant epoxygenase in the rodent brain 32 , labeled AQP4-expressing endfeet along larger vessels, but not along capillaries (Supplementary Fig. 5c ). Furthermore, antibodies against PGE 2 synthase (PGES) also labeled GFAP-expressing astrocyte cell bodies, processes and endfeet (Supplementary Fig. 5d ). These findings are consistent with the functional data in Figure 4 suggesting that PGE 2 is the main vasoactive metabolite of AA that signals to capillaries and that it is synthesized within astrocytes. 7) (7) (9) (6) (13) (8) (23) (14) Stim-evoked Ca or NO synthase with l-NNA (100 µM; i) has no effect on capillary dilation. (j-l) Mean data showing that capillary dilation is blocked by L-161,982 (j), but not by CAY10441 (k) or l-NNA (l). Box and whisker plots as defined in Figure 1 . P values are from appropriate t-tests, as defined in the Statistics section of the Online Methods.
a r t I C l e S PLD2, not PLA2, initiates neurovascular coupling at the capillary level The Ca 2+ -dependent enzyme PLA2 is thought to synthesize the AA that is converted into PGE 2 (refs. 2, 8, 33) . We found that PLA2 immunolabeling colocalized with GFAP on astrocyte endfeet along capillaries (Supplementary Fig. 6 ), suggesting a possible role for this enzyme. Surprisingly, however, stimulation-evoked capillary dilation was unchanged when PLA2 was blocked with its inhibitor MAFP (10 µM, Fig. 5a,d) . Thus, despite being in the correct cellular compartment, PLA2 is not the primary enzyme involved in the AA synthesis required for signaling to capillaries. We therefore sought other possible AA sources.
The enzymes phospholipase C (PLC) and PLD can produce AA via a multistep process. PLC breaks down phosphatidylinositol-4,5bisphosphate to DAG (diacylglycerol) and IP 3 , while PLD acts on membrane phospholipids to synthesize phosphatidic acid, which is then converted to DAG by phosphatidate phosphatase. DAG produced by PLC or PLD in this way can be further metabolized by DAG lipase (DAGL) to produce AA. A specific blocker of PLC, U73122 (10 µM), did not reduce stimulation-evoked capillary dilation ( Fig. 5b,e ). In contrast, the PLD-specific blocker FIPI (4-fluoro-N-(2-(4-(5-fluoro-1Hindol-1-yl)piperidin-1-yl)ethyl)benzamide,1 µM) reduced dilation by 64% (P = 0.0005; Fig. 5c,f) , suggesting that PLD plays a major role in synthesizing AA. Two isoforms of PLD are expressed in mammals, PLD1 and PLD2, both of which are regulated 34, 35 by Ca 2+ . A specific inhibitor of PLD1, VU0155069 (500 nM), had no effect on stimulation-evoked dilation (Fig. 5g,j) ; however, a blocker of PLD2, CAY10594 (1 µM), completely abolished the capillary dilation (P = 0.0002; Fig. 5h,k) , suggesting that AA synthesis is PLD2 dependent. If so, then the downstream enzyme DAGL, which is required for AA production from DAG, should also be involved. Indeed, the DAGL inhibitor RHC80267 (50 µM) also blocked the stimulation-evoked capillary dilation (reduced by 81%, P = 0.0004; Fig. 5i,l) , suggesting the PLD2-DAGL pathway as the mechanism for AA synthesis.
We considered whether PLD2 might, instead of being in the pathway for AA synthesis, be activated downstream of the PGE 2 receptor EP4 in pericytes to cause the capillary dilation. However, there was no difference between PGE 2 -induced dilation of cortical capillaries in the absence (8.1 ± 1.7%) and presence (8.5 ± 2.1%) of the PLD blocker FIPI (Supplementary Fig. 7) , supporting our conclusion that the PLD2-DAGL pathway is upstream of AA synthesis.
Consistent with these results, immunolabeling for PLD1 showed that it was expressed diffusely in the neuropil and strongly in endothelial cells lining arterioles (Supplementary Fig. 8a) , but it was not in astrocyte endfeet, pericytes or capillary endothelial cells ( Supplementary Fig. 8a,b) . In contrast, PLD2 immunolabeling occurred in GFAP-positive astrocyte endfeet on capillaries (Supplementary Fig. 8c ) and cell bodies (Supplementary Fig. 8d ), but not in pericytes or endothelial cells, consistent with a role in astrocyte-mediated neurovascular signaling to capillary pericytes.
Arteriole dilation is mediated by a different signaling pathway
To compare the data above on capillary dilation with the dilation of arterioles evoked by neuronal activity, we carried out similar experiments imaging arterioles. U46619 preconstricted arterioles by 11.8 ± 0.8% (n = 36 arterioles from 26 animals, Supplementary Fig. 9 ). The neuronal-stimulation-evoked dilation of arterioles (7.0 ± 0.7%, n = 36; mean of all control data in Fig. 6 ) was smaller than that evoked in capillaries (12.1 ± 1.9%; Supplementary Fig. 4b ; both with 5 s stimulation). Remarkably, in contrast to the capillary dilation, the arteriole dilation was unaffected by dialyzing the astrocyte network with BAPTA ( Fig. 6a,b) or by blocking P2X1 receptors, PLD2 or PLA2 ( Fig. 6c-e,h,i) , indicating that a completely different signaling pathway, independent of astrocyte [Ca 2+ ] i changes, mediates arteriole dilation. However, again unlike the capillary dilation ( Figs. 1h and 4l) , arteriole dilation was strongly inhibited by blocking NMDA receptors (P = 0.008, Fig. 6f,j) or NO synthase (P = 10 −6 , Fig. 6g,k) .
Neurovascular signaling in vivo
To determine whether the ATP-dependent astrocyte signaling mechanism also mediates neurovascular coupling at the capillary level in vivo, we used two-photon excitation fluorescence microscopy to image cortical capillaries and arterioles in vivo in anesthetized rats, with intravascular FITC-dextran to visualize the blood vessels (Fig. 7a,b and Online Methods). We evoked neuronal activity in the somatosensory cortex by electrically stimulating the forepaw. The diameter of all imaged capillaries was 6.7 ± 0.2 µm (n = 102) and that of arterioles was 13.4 ± 0.5 µm (n = 77). Forepaw stimulation evoked dilation in 22% of capillaries and 24% of arterioles ( Fig. 7c-e ). a r t I C l e S In those vessels, capillary dilation averaged 29.3 ± 5.8% and arteriole dilation averaged 10.9 ± 2.2% (Fig. 7f) .
Local infusion of the P2X1 blocker NF449 (5 µM) into the cortical region did not significantly affect the percentage of capillaries dilating (reduced to 13%, P = 0.3, Fig. 7e ). However, the capillary dilations that did occur were reduced by 68% in size to 9.5 ± 1.8% (P = 0.006, Fig. 7d,f) . In contrast, NF449 did not significantly alter either the percentage of dilating arterioles (18%, P = 0.6) or the magnitude of the arteriole dilations (9.7 ± 1.7%, P = 0.7; Fig. 7c,e,f) , just as in slices (Fig. 6h) .
DISCUSSION
Neurovascular coupling plays a crucial role in controlling cerebral blood flow, both physiologically and in disease. Capillary dilation a r t I C l e S generates a large portion of the blood flow increase evoked by neuronal activity and thus is expected to contribute substantially to the BOLD signal 6 . In ischemia, pericytes constrict capillaries, contributing to the lack of reperfusion of the microvasculature that occurs after a thrombus is removed from an upstream artery 6, 36 .
Consequently, characterizing the signaling mechanisms that regulate capillary and arteriole dilation is important for understanding the blood flow response to physiological activity and to disease. In this study, we have demonstrated that neurovascular coupling at the capillary and arteriole levels differ mechanistically ( Supplementary  Fig. 1) . Neurovascular coupling at the capillary level is largely dependent on astrocyte Ca 2+ signaling, and our data reveal a new mechanism by which astrocytes alter their [Ca 2+ ] i in response to neuronal activity: influx of Ca 2+ via the ionotropic ATP receptor P2X1. Thus astrocyte [Ca 2+ ] i can be raised without a need for mGluR5 (ref. 37 ) and IP 3 R2-mediated signaling, which have recently been suggested to be unnecessary for neurovascular coupling in adult animals 15, 16, 38 , and astrocyte Ca 2+ transients observed in IP 3 R2 knockout mice 39 may partly reflect activation of P2X1 receptors. Our data are consistent with work showing that overexpression of an ectonucleotidase (to promote rapid ATP degradation) strongly reduces BOLD fMRI signals triggered by somatosensory stimulation in rats 40 . We also show that, although signaling to capillaries is mediated by AA metabolites, the synthesis of AA depends not upon PLA2, as generally assumed 2,8 , but rather on PLD2 and DAGL activity. Furthermore, neuronal activity induced capillary dilation is unaffected by block of NO synthase (thus differing from the pericyte-mediated dilation we previously characterized in cerebellum 6 , presumably because of the difference in brain region, as the cerebellum expresses more NOS, and/or because dilation was evoked by glutamate superfusion in the latter study but by endogenous glutamate release here). In contrast, neurovascular signaling to cortical arterioles is not mediated by P2X1, astrocyte Ca 2+ , PLD2 or PLA2 but, unlike cortical capillary dilation, requires the activation of NMDA receptors and production of NO. Our data suggest that neuronal activity results in postsynaptic neurons ( Fig. 1) releasing ATP, which acts on astrocyte ATP receptors containing P2X1 subunits to produce a [Ca 2+ ] i rise ( Figs. 2 and 3) . This activates PLD2 ( Fig. 5 and Supplementary Fig. 8) , resulting in AA synthesis via DAGL and downstream metabolism by COX1 into vasodilatory PGE 2 , which is released onto capillary pericytes to induce dilation via the EP4 receptor ( Fig. 4 and Supplementary Fig. 5 ). P2X1 receptors are expressed in cortical astrocytes along with P2X5 receptors 19 , which can together form heterotrimers and contribute to Ca 2+ influx. The astrocyte Ca 2+ influx causing capillary dilation (Figs. 2, 3 and 7 and Supplementary Fig. 4 ) may be via P2X1 homotrimers or P2X1/5 heterotrimers 19 , as both are blocked by NF449 and activated by α,β-methylene-ATP (puffed onto the neuropil ; Fig. 2h,m  and Supplementary Fig. 10) . Although it was previously reported that ATP is released 40 from presynaptic terminals 41 , we show that NBQX blocks the capillary dilation, implying that postsynaptic glutamate receptor activation is needed for ATP release, at least in the cortex. The mechanism of this ATP release has yet to be investigated.
In contrast to capillary dilation, arteriole dilation does not depend on P2X1 receptors, PLA2, PLD2 or astrocyte calcium signaling, but is dependent on NMDA receptor activation and NO synthesis ( Figs. 6 and 7) , as previously suggested 30, 31 . It has been suggested that activation of NMDA receptors, by Ca 2+ -dependent release of d-serine from astrocytes, generates NO from endothelial NOS in endothelial cells and thus helps to dilate penetrating arterioles 31 . Our data showing that buffering astrocyte [Ca 2+ ] i does not inhibit arteriole dilation (Fig. 6a,b) argue against a role for astrocyte Ca 2+ in triggering arteriole dilation in our experiments, and furthermore transcriptome data suggest there are no NMDA receptors on endothelial cells 42 . We therefore assume that the NO is generated by neuronal NOS, which is Ca 2+ dependent and predominantly located in interneurons in the cortex 43, 44 .
It has previously been suggested that, in the cortex, NO release is needed to maintain neurovascular coupling but not to mediate it 45 . This is similar to the idea that, in cortex 31 and in cerebellum 6 , NO serves to suppress the generation of the vasoconstrictor 20-HETE from AA while another AA derivative, PGE 2 , dilates the arterioles. We have shown that blocking AA production by inhibiting PLA2 or PLD2 has no effect on the arteriole dilation evoked by neuronal activity (Fig. 6d,e,i) , leading us to favor the idea that NO may directly mediate arteriole dilation in our preparation. However, we cannot rule out the possibility that AA is generated by PLC and DAG lipase, and that downstream generation of PGE 2 (or EETs; see below) dilates the arterioles provided that NO suppresses 20-HETE formation.
The lack of dependence of arteriole dilation on astrocyte [Ca 2+ ] i changes contrasts with earlier work 1-3 in which mGluR agonists or Ca 2+ uncaging evoked arteriole dilation by raising astrocyte [Ca 2+ ] i . We assume this relates to the different kinds of stimuli applied: release of endogenous neurotransmitter glutamate from synapses in this paper versus the generation of a more spatially extensive [Ca 2+ ] i rise by bath superfusion of an mGluR agonist or essentially simultaneous Ca 2+ uncaging in several astrocytes. Consequently, we cannot exclude the possibility that with other stimulation procedures (or in other brain regions) mGluR-driven astrocyte Ca 2+ signaling may contribute to arteriole dilation, although this mechanism may decrease in importance with age 15 .
Overall, our data indicate that two cellularly and chemically distinct Ca 2+ -dependent pathways mediate neurovascular coupling in response to neuronal-activity-evoked glutamate release (Supplementary Fig. 1) : ATP-evoked signaling in astrocytes generates PGE 2 , which dilates capillaries via pericytes, and glutamate-evoked NO release from interneurons dilates arterioles. Previous data 6 suggest that the astrocyte-capillary pathway is faster, and quantitatively more important for increasing blood flow, than the interneuronarteriole pathway, so our current data imply that purinergic signaling contributes substantially to generating BOLD signals.
We observed a similar block of capillary dilation after astrocyte Ca 2+ buffering (64% reduction: Fig. 2c ) and inhibition of P2X1 receptors (58% reduction: Fig. 2l ). The incomplete nature of this block (compared to that produced by inhibiting PLD2 : Fig. 5k ) may reflect an insufficient concentration of BAPTA or NF449 being applied. Alternatively, another mechanism might generate the remaining fraction of the response. We have ruled out direct signaling from neurons to pericytes via NMDA receptor mediated NO release 30 (Fig. 1e,h and 4i,l) , but other signals or Ca 2+ -independent (for example, cyclic nucleotide) mechanisms in astrocytes could be involved.
Previous reports have suggested that astrocyte-mediated neurovascular signaling involves AA metabolites, and our data demonstrate that this is true for signaling to capillaries. Conceivably, EETs may contribute to neurovascular signaling to arterioles under some conditions 9,46,47 , as we detected epoxygenase expression in astrocyte endfeet along larger vessels (but not in endfeet along capillaries (Supplementary Fig. 5c ), and EETs do not contribute to capillary dilation 6 ; Fig. 4c,f) . Although AA production has been attributed to the activity of Ca 2+ -dependent 48 PLA2 (refs. 2, 8) , which is expressed in astrocytes 33 (Supplementary Fig. 6 ), we found that PLA2 was not involved in neurovascular coupling. Instead, another Ca 2+ -dependent phospholipase, PLD2, was responsible for AA production (Fig. 5h,k a r t I C l e S and Supplementary Fig. 8c,d) . In the brain, PLD1 may be expressed primarily in neurons or oligodendrocytes and PLD2 in astrocytes 34, 49 . Furthermore, studies of the two PLD isoforms have suggested that PLD1 is expressed in endosomal compartments, depending on Ca 2+ release from internal stores for activation, whereas PLD2 tends to be membrane associated and is activated by Ca 2+ entry through ion channels 34, 35 . Our findings suggest that astrocytic PLD2 is activated by Ca 2+ entry through P2X1 channels, which fits neatly with these data.
In conclusion, neuronal activity results in capillary dilation in a manner that is largely dependent on Ca 2+ -dependent signaling in astrocytes. The astrocyte [Ca 2+ ] i rise causing dilation depends on ionotropic P2X1 receptor activation, but not on G-protein-coupled receptors or TRPA1 channels. AA synthesis via a PLD2-DAGL pathway and downstream metabolism into prostaglandin E 2 by COX1 are necessary for capillary dilation, with the required synthetic enzymes being expressed in astrocytes. In contrast, neuronally evoked arteriole dilation depends at least partly on the activation of neuronal NMDA receptors and subsequent synthesis and release of NO. These data demonstrate that astrocytes are important contributors to neurovascular coupling at the capillary level and suggest that capillaries, which contain most of the resistance to blood flow in the brain parenchyma 50 , could be specifically targeted therapeutically to increase blood flow in pathological conditions. Note added in proof: consistent with this paper, Biesecker et al. 51 have just reported that, in the retina, glial Ca 2+ signaling regulates capillary but not arteriole diameter.
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ONLINE METHODS
Animals. Sprague-Dawley rats of both sexes were used in all experiments. Animal procedures were carried out in accordance with the guidelines of the UK Animals (Scientific Procedures) Act 1986 and European Directive 2010/63/EU under the oversight of the UK government Home Office. Each experiment was conducted on brain slices from at least three animals (at least one of each sex).
Brain slice preparation. As described previously 22 , 300-µm-thick coronal cortical slices were prepared from P21 rats on a vibratome in ice-cold oxygenated (95% O 2 , 5% CO 2 ) solution containing (in mM) 93 N-methyl-d-glucamine chloride, 2.5 KCl, 30 NaHCO 3 , 10 MgCl 2 , 1.2 NaH 2 PO 4 , 25 glucose, 0.5 CaCl 2 , 20 HEPES, 5 sodium ascorbate, 3 sodium pyruvate and 1 kynurenic acid. The slices were incubated at 34 °C in the same solution for 15-20 min, then transferred to a similar solution with the NMDG chloride, MgCl 2 and CaCl 2 replaced by (mM) 93 NaCl, 1 MgCl 2 and 2 CaCl 2 , and incubated at room temperature (21-23 °C) until used in experiments.
Imaging of capillaries in brain slices. Slices were perfused with bicarbonate buffered aCSF containing (in mM) 124 NaCl, 2.5 KCl, 26 NaHCO 3 , 1 MgCl 2 , 2 CaCl 2 , 1 NaH 2 PO 4 , 10 glucose, 1 sodium ascorbate, heated to 31-35 °C and gassed with 20% O 2 , 5% CO 2 and 75% N 2 . Capillaries were imaged using differential interference contrast (DIC) microscopy at 20-50 µm depth within layers III-VI of cortical slices containing the motor and prefrontal cortices, using a 40× water immersion objective, a Coolsnap HQ2 CCD camera, and ImagePro Plus acquisition software. Images were acquired every 5 s, with an exposure time of 100 ms. The pixel size was 160 nm. The thromboxane A 2 analog U46619 (200 nM) was used to preconstrict capillaries in all experiments where the vessel response to stimulation was evaluated. Although the cerebral cortex is highly vascularized, the slicing procedure leaves many vessels unhealthy and unable to actively respond to stimuli 22 . We only analyzed vessels that preconstricted to U46619, in order to ensure that the vessels used in our experiments were healthy and responsive. Vessel internal diameters were measured by manually placing a measurement line perpendicular to the vessel (Fig. 1a) on the image at locations where constriction to U46619 occurred (presumed regions of active pericyte control) using Metamorph software. Change in diameter was quantified as a 30 s average centered around the largest response seen after stimulation, normalized to the baseline diameter. Experiments in which changes in focus occurred were excluded from further analysis. Data in the presence of blockers of signaling pathways were compared with interleaved control data obtained without the blockers to avoid confounds due to day-to-day variability in stimulation-evoked capillary responses. Control and drug experiments were randomly interleaved. To reduce experimenter bias, experiments were conducted and analyzed blind when possible (i.e. all experiments except when the drug was colored, for example, NBQX).
Stimulation protocol for brain slices. High frequency (100 Hz) trains of short duration (200 ms (30-90 V, 0.2 ms)), medium duration (the short stimulation repeated once per second for 5 s) or long duration (the short stimulation repeated once per second for 1 min) were applied using an aCSF-filled patch pipette electrode placed 400-500 µm from the imaged vessel. All stimulation durations evoked a capillary dilation with the same pharmacology (blocked by NF449: see Supplementary Fig. 4 ). All arteriole experiments were conducted using the 5-s, medium duration stimulation. To confirm activation of the neurons, the field potential was monitored near the capillary of interest using a 4 MΩ patch pipette filled with aCSF ( Supplementary Fig. 2a,b) , and only experiments where a field potential was detected were used for analysis. When characterizing field potentials in detail ( Supplementary Fig. 2) , a 25-s-long, 12 Hz stimulation was used and the peak EPSC amplitude between 5 and 9 ms after stimulation was measured.
Pharmacology in brain slices. For all experiments except those using L-161,982 and PPOH, vessels were preconstricted with U46619, which acts on thromboxane A 2 receptors (unpublished data kindly provided by Ben Barres (Stanford University), similar to those at http://web.stanford.edu/group/barres_lab/brain_ rnaseq.html, show that pericytes express this receptor). The drug of interest was then bath applied for at least 5 min before stimulation-evoked capillary responses were evaluated. For L-161,982 experiments, slices were treated with L-161,982 for 5 min before preconstriction was achieved with U46619 (applied for 5 min) and stimulation-evoked dilations were then evaluated. This allowed us to confirm that PGE 2 signaling via EP4 does not contribute to baseline capillary tone (constricted by 3.3 ± 3.0%; P = 0.3). Slices were incubated in PPOH for at least 1 h before experiments and PPOH was included in all solutions (control and U46619-containing aCSF) to ensure that epoxygenase activity was blocked during stimulation experiments. A list of the drugs used is given in Supplementary  Table 1 , along with the concentration and timeframe on which they have previously been shown to act. a,b-Methylene-ATP puff experiments. A 5-s puff of external solution containing α,β-methylene-ATP (100 µM) was used to activate P2X1 receptors. ATP can constrict retinal pericytes and arterioles directly 5, 52 , and here we found the same effect when α,β-methylene-ATP was bath applied to cortical slices (8.4 ± 2.7% constriction, n = 5). To avoid these direct effects of α,β-meATP on the vessel, the puff pipette was positioned 100-150 µm downstream (with respect to the perfusion flow) from the capillary of interest, with the aim of activating astrocytes at that location that would then signal to the imaged vessel. Lack of spread of the puffed solution to the imaged vessel was confirmed by including a dye in the puffing pipette on some occasions (Supplementary Fig. 10 ).
whole-cell patch-clamping of astrocytes. Slices were superfused with bicarbonate-buffered solution as described above, bubbled with 20% O 2 , 5% CO 2 and 75% N 2 , and heated to 33-36 °C. Astrocytes were identified as cells with a soma of small diameter (~10 µm) that was not perfectly round. In some cases, slices were incubated at a very low concentration of Rhod-2 AM (4 µM), which loads relatively selectively into astrocytes and NG2-positive oligodendrocyte precursor cells. Astrocytes were whole-cell clamped at −80 mV with 3-5 MΩ patch pipettes with different internal solutions depending on the experiment being carried out. The control internal solution contained (in mM) 125 potassium gluconate, 2 NaCl, 0.1 CaCl 2 , 10 HEPES, 1 tetrapotassium EGTA, 2 MgCl 2 , 2 Na 2 -ATP, 0.5 Na 2 -GTP, 10 disodium phosphocreatine and 0.04 Alexa Fluor 488, with pH set to 7.1 using KOH. The internal solution containing BAPTA (tetrapotassium salt) was similar but with the CaCl 2 and EGTA replaced with (in mM) 3 CaCl 2 and 30 BAPTA (so that the free [Ca 2+ ] i was ~24.5 nM in both the control and the BAPTA internal solutions, calculated using MaxChelator (http://maxchelator.stanford.edu/webmaxc/webmaxcE.htm) with the temperature set to 35 °C and ionic strength set to 145 mM) and with osmolarity differences compensated by lowering the potassium gluconate concentration. Osmolarity measurements showed that tetrapotassium BAPTA does not dissociate completely so that correspondingly less compensation of osmolarity was needed. The solution contained (mM) 67 potassium gluconate, 2 NaCl, 3 CaCl 2 , 10 HEPES, 30 tetrapotassium BAPTA, 2 MgCl 2 , 2 Na 2 -ATP, 0.5 Na 2 -GTP, 10 disodium phosphocreatine and 0.04 Alexa Fluor 488, with pH set to 7.1 using KOH. Patch-clamped cells were confirmed to be astrocytes morphologically by their arborization pattern revealed by dye filling and electrically by their large negative resting membrane potential (-91.6 ± 0.6 mV, n = 33), low input resistance (4.6 ± 0.6 MΩ) and passive I-V relationship.
